This Ashish Dhawan-backed pharma stock zoomed over 100% in 2 straight years

Q: How long will it take to read this news story?

The story "This Ashish Dhawan-backed pharma stock zoomed over 100% in 2 straight years" has 619 words across 24 sentences, which will take approximately 3 - 6 minutes for the average person to read.

Q: Which news outlet covered this story?

The story "This Ashish Dhawan-backed pharma stock zoomed over 100% in 2 straight years" was covered 6 days ago by Business Standard, a news publisher based in India.

Q: How trustworthy is 'Business Standard' news outlet?

Business Standard is a fully independent (privately-owned) news outlet established in 1975 that covers mostly business and finance news. The outlet is headquartered in India and publishes an average of 127 news stories per day. It's most recent story was published 2 hours ago.

Q: What do people currently think of this news story?

The sentiment for this story is currently Negative, indicating that people regard this as "bad news".

Q: How do I report this news for inaccuracy?

You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.<ul><li>News ID: #22648175</li><li>URL: https://beamstart.com/news/this-ashish-dhawan-backed-pharma-17270668601051</li></ul>

Business Standard Logo Business Standard 6d ago

This Ashish Dhawan-backed pharma stock zoomed over 100% in 2 straight years - Business Standard

Quick Summary:

Glenmark Pharma rallied nearly 9% to Rs 1,763.90 after the US drug regulator issued Form 483 with zero observations for its formulation manufacturing facility in Aurangabad.

Glenmark Pharmaceuticals is primarily engaged in the business of development, manufacturing and marketing of pharmaceutical products.

At 09:36 AM, Glenmark Pharma was trading 8 per cent higher at Rs 1,749.90, as compared to 0.29 per cent rise in the BSE Sensex.